Developer docs
API playgroundTry for free, no card

Search company profiles

eurofarma, sociedad anonima

Full company profile

uuid02mignq

Namestring
eurofarma, sociedad anonima
Legal namestring
Eurofarma Laboratórios S.A.
Company typeenum
Private
Founded yearint
1972
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersItapevi, Brazil
HQ citystring
Itapevi
HQ countrystring
Brazil
HQ regionstring
Latin America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical manufacturing, generic medicines, prescription medications, veterinary pharmaceuticals, oncology therapeutics
Industry2 codes
1Global Supply Chain, Procurement & Market-Shaping Partnerships (Medicines/Diagnostics/Vaccines)
CodeHLAJAOAKPrimaryYes
2Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC)
CodeHLAGAHAMPrimaryNo
NAICS code3 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Pharmaceutical and Medicine Manufacturing3254
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Pharmaceutical Manufacturing
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Products
TypeOne Time License
Description

Eurofarma manufactures and commercializes pharmaceutical products including prescription medications, OTC products, and health-related products through pharmacies and healthcare providers across Latin America.

eurofarma.com.gt
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Others
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 7 records shown
1Momenta
Description

Pharmaceutical brand focused on consumer health products including wellness and lifestyle medications.

eurofarma.com.gt
+6 more records
Core offering1 text field

Eurofarma manufactures and commercializes a broad portfolio of pharmaceutical products including prescription medications, generic medicines, over-the-counter products, hospital medicines, and oncology therapeutics across more than 20 countries in Latin America and Africa. The company distributes through pharmacy networks, healthcare professional channels, and B2B partner networks, and operates supporting platforms including the +Verde sustainable packaging seal initiative, EuroCuida patient discount programs, and EurON Pro healthcare professional platform. The group also encompasses veterinary pharmaceuticals (Pearson Saúde Animal), consumer health (Momenta), and a human milk bank (Lactare).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • 49.5 million+ medications with +Verde seal sold since 2018, reducing 1.56 tons of carbon equivalent
Product overview1 text field

Eurofarma is a pharmaceutical company with over 50 years of history operating in more than 20 countries. The company offers a portfolio of pharmaceutical products across various therapeutic categories, supplemented by patient support programs like EuroCuida, customer service through its CAE center, and sustainability-focused products marked with the +Verde eco-seal. Additional services include a restricted access portal for healthcare professionals, pharmacovigilance reporting, health education content, and an indicator center for financial and ESG performance transparency.

Product and service3 records
1Pharmaceutical Product Portfolio
CategoryPharmaceutical Manufacturing
2+Verde (Eco-Friendly Pharmaceutical Line)
CategoryPharmaceutical Manufacturing - Sustainable Products
3EuroCuida Semaglutide Discount Program
Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2018-01-01
Description

ANVISA validated Eurofarma's unique domestic decontamination methodology for blister packaging - a globally unprecedented process developed by Eurofarma. This regulatory validation enables the +Verde seal certification.

2Universidade São Camilo
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaboration with Universidade São Camilo for clinical care support in the lactation process, demonstrating commitment to maternal and child health programs.

eurofarma.com.gt
Strategic tierMinorTypeGTM or Marketing Partner
Description

Eurofarma maintains a proprietary Stock Car racing team for 20 years as part of sports sponsorship and brand visibility initiatives.

Peers10 records
TypeDirect peer
Description

Brazil's largest pharmaceutical company by units sold, with a similar generics-anchored portfolio across prescription, OTC, and hospital segments in the Brazilian market. EMS competes head-to-head with Eurofarma in domestic tenders, pharmacy distribution, and therapeutic categories, making it the closest direct peer.

TypeDirect peer
Description

Major Brazilian pharmaceutical manufacturer with leading positions in OTC, generics, and consumer health, plus a strong branded portfolio. Hypera competes with Eurofarma across retail pharmacy channels and has overlapping therapeutic coverage in Brazil and select LatAm markets.

TypeDirect peer
Description

Brazilian pharmaceutical company with branded prescription, generic, and OTC products plus an oncology franchise. Aché's therapeutic breadth, oncology focus, and domestic manufacturing footprint make it a direct comparable in the Brazilian prescription and specialty pharma market.

TypeDirect peer
Description

Mid-to-large Brazilian pharmaceutical company with a prescription and hospital-focused portfolio including cardiovascular, women's health, and specialty therapeutics. Biolab's hospital channel presence and branded prescription approach overlap with Eurofarma's hospital and oncology segments.

TypeEmerging player
Description

Indian generic manufacturer with a substantial emerging-markets commercial footprint including Brazil and other LatAm countries. Aurobindo's cost advantage in API and finished generics makes it both a supply-side competitor and a source of pricing pressure on Eurofarma's generics portfolio across the region.

TypeEmerging player
Description

South African pharmaceutical company operating across Africa and select emerging markets with branded generics and specialty pharma franchises. Aspen's emerging-market-focused commercial model, regulatory infrastructure across multiple African jurisdictions, and therapeutic breadth parallel Eurofarma's LatAm/Africa multi-country playbook.

TypeEmerging player
Description

Indian pharmaceutical manufacturer with a branded generics focus and growing international presence in Brazil, Mexico, and other LatAm markets. Torrent's emerging-market expansion and therapeutic breadth position it as an international comparable to Eurofarma's growth trajectory.

TypeBroad incumbent
Description

Global pharma major with a Brazilian generics franchise (historically known as Medley) plus branded specialty products. Sanofi competes with Eurofarma across generics and branded segments in Brazil and other LatAm markets while bringing global scale advantages.

TypeBroad incumbent
Description

Global pharmaceutical and consumer health company with established LatAm operations across prescription, consumer health, and animal health. Bayer's animal health overlap with Eurofarma's Pearson Saúde Animal subsidiary and its consumer health portfolio create comparable adjacencies.

TypeBroad incumbent
Description

Global animal health leader spun off from Pfizer, with significant LatAm veterinary pharmaceutical presence. Zoetis serves as the global benchmark for Eurofarma's Pearson Saúde Animal veterinary subsidiary in terms of therapeutic breadth, market position, and margin profile.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries5 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

eurofarma, sociedad anonima

Pharmaceutical Manufacturingeurofarma.com.gt

eurofarma, sociedad anonima firmographics

Firmographics
Name
eurofarma, sociedad anonima
Legal name
Eurofarma Laboratórios S.A.
Website
https://eurofarma.com.gt
Company type
Private
Founded year
1972
Operating status
Operating
Headcount range
5,001–10,000 employees
Ownership category
akta.pro rank

eurofarma, sociedad anonima industry classification

Industry
Product category
Pharmaceutical Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
SIC
Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro primary industry
Global Supply Chain, Procurement & Market-Shaping Partnerships (Medicines/Diagnostics/Vaccines) (HLAJAOAK)
akta.pro secondary industry
Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)

Keywords

  • Pharmaceutical manufacturing
  • Generic medicines
  • Prescription medications
  • Veterinary pharmaceuticals
  • Oncology therapeutics

Where eurofarma, sociedad anonima is headquartered

Location

Headquarters

HQ city
Itapevi
HQ country
Brazil
HQ region
Latin America

Offices1 record

Markets served

eurofarma, sociedad anonima business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Pharmaceutical Products: Eurofarma manufactures and commercializes pharmaceutical products including prescription medications, OTC products, and health-related products through pharmacies and healthcare providers across Latin America.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

eurofarma, sociedad anonima product offering

Product offering

Core offering

Eurofarma manufactures and commercializes a broad portfolio of pharmaceutical products including prescription medications, generic medicines, over-the-counter products, hospital medicines, and oncology therapeutics across more than 20 countries in Latin America and Africa. The company distributes through pharmacy networks, healthcare professional channels, and B2B partner networks, and operates supporting platforms including the +Verde sustainable packaging seal initiative, EuroCuida patient discount programs, and EurON Pro healthcare professional platform. The group also encompasses veterinary pharmaceuticals (Pearson Saúde Animal), consumer health (Momenta), and a human milk bank (Lactare).

Product overview

Eurofarma is a pharmaceutical company with over 50 years of history operating in more than 20 countries. The company offers a portfolio of pharmaceutical products across various therapeutic categories, supplemented by patient support programs like EuroCuida, customer service through its CAE center, and sustainability-focused products marked with the +Verde eco-seal. Additional services include a restricted access portal for healthcare professionals, pharmacovigilance reporting, health education content, and an indicator center for financial and ESG performance transparency.

Differentiator

Problem solved

Functional benefit

Brands

  • Momenta: Pharmaceutical brand focused on consumer health products including wellness and lifestyle medications.
  • EuroCuida
  • Pearson Saúde Animal
  • Instituto Eurofarma
  • Lactare
  • EurON Pro
  • +Verde (+Green)

Products and services

  • Pharmaceutical Product Portfolio
  • +Verde (Eco-Friendly Pharmaceutical Line)
  • EuroCuida Semaglutide Discount Program

Quantifiable outcome

  • 49.5 million+ medications with +Verde seal sold since 2018, reducing 1.56 tons of carbon equivalent

Companies that use eurofarma, sociedad anonima

Customer profile

Segments3 records

Ideal customer profiles3 records

eurofarma, sociedad anonima technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

eurofarma, sociedad anonima partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • ANVISA (Brazilian Health Regulatory Agency)coreStrategic or Co-development Partner · 1 January 2018ANVISA validated Eurofarma's unique domestic decontamination methodology for blister packaging - a globally unprecedented process developed by Eurofarma. This regulatory validation enables the +Verde seal certification.
  • Universidade São CamilominorStrategic or Co-development PartnerCollaboration with Universidade São Camilo for clinical care support in the lactation process, demonstrating commitment to maternal and child health programs.
  • Stock Car Racing TeamminorGTM or Marketing PartnerEurofarma maintains a proprietary Stock Car racing team for 20 years as part of sports sponsorship and brand visibility initiatives.

Scale indicators10 records

eurofarma, sociedad anonima competitors and assessment

Company assessment

Direct peers

  • EMS Pharma: Brazil's largest pharmaceutical company by units sold, with a similar generics-anchored portfolio across prescription, OTC, and hospital segments in the Brazilian market. EMS competes head-to-head with Eurofarma in domestic tenders, pharmacy distribution, and therapeutic categories, making it the closest direct peer.
  • Hypera Pharma: Major Brazilian pharmaceutical manufacturer with leading positions in OTC, generics, and consumer health, plus a strong branded portfolio. Hypera competes with Eurofarma across retail pharmacy channels and has overlapping therapeutic coverage in Brazil and select LatAm markets.
  • Aché Laboratórios: Brazilian pharmaceutical company with branded prescription, generic, and OTC products plus an oncology franchise. Aché's therapeutic breadth, oncology focus, and domestic manufacturing footprint make it a direct comparable in the Brazilian prescription and specialty pharma market.
  • Biolab Sanus Farmacêutica: Mid-to-large Brazilian pharmaceutical company with a prescription and hospital-focused portfolio including cardiovascular, women's health, and specialty therapeutics. Biolab's hospital channel presence and branded prescription approach overlap with Eurofarma's hospital and oncology segments.

Emerging players

  • Aurobindo Pharma: Indian generic manufacturer with a substantial emerging-markets commercial footprint including Brazil and other LatAm countries. Aurobindo's cost advantage in API and finished generics makes it both a supply-side competitor and a source of pricing pressure on Eurofarma's generics portfolio across the region.
  • Aspen Pharmacare: South African pharmaceutical company operating across Africa and select emerging markets with branded generics and specialty pharma franchises. Aspen's emerging-market-focused commercial model, regulatory infrastructure across multiple African jurisdictions, and therapeutic breadth parallel Eurofarma's LatAm/Africa multi-country playbook.
  • Torrent Pharmaceuticals: Indian pharmaceutical manufacturer with a branded generics focus and growing international presence in Brazil, Mexico, and other LatAm markets. Torrent's emerging-market expansion and therapeutic breadth position it as an international comparable to Eurofarma's growth trajectory.

Broad incumbents

  • Eurofarma's Medley/Sanofi (sanofi-aventis Brazil): Global pharma major with a Brazilian generics franchise (historically known as Medley) plus branded specialty products. Sanofi competes with Eurofarma across generics and branded segments in Brazil and other LatAm markets while bringing global scale advantages.
  • Bayer Pharmaceuticals: Global pharmaceutical and consumer health company with established LatAm operations across prescription, consumer health, and animal health. Bayer's animal health overlap with Eurofarma's Pearson Saúde Animal subsidiary and its consumer health portfolio create comparable adjacencies.
  • Zoetis: Global animal health leader spun off from Pfizer, with significant LatAm veterinary pharmaceutical presence. Zoetis serves as the global benchmark for Eurofarma's Pearson Saúde Animal veterinary subsidiary in terms of therapeutic breadth, market position, and margin profile.

Market position

Strengths5 records

Weaknesses5 records

Key risks6 records

Key highlights7 records

Customer concentration

eurofarma, sociedad anonima social profiles

Digital presence

eurofarma, sociedad anonima compliance and trust

Trust signal

Compliance4 records

eurofarma, sociedad anonima financial estimates

Financial estimate

Revenue estimate

Valuation estimate

eurofarma, sociedad anonima leadership team

Management profile

Number of profiles

eurofarma, sociedad anonima subsidiaries and ownership

Company hierarchy

Subsidiaries5 records

eurofarma, sociedad anonima funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

eurofarma, sociedad anonima M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about eurofarma, sociedad anonima

What does eurofarma, sociedad anonima do?

Eurofarma manufactures and commercializes a broad portfolio of pharmaceutical products including prescription medications, generic medicines, over-the-counter products, hospital medicines, and oncology therapeutics across more than 20 countries in Latin America and Africa. The company distributes through pharmacy networks, healthcare professional channels, and B2B partner networks, and operates supporting platforms including the +Verde sustainable packaging seal initiative, EuroCuida patient discount programs, and EurON Pro healthcare professional platform. The group also encompasses veterinary pharmaceuticals (Pearson Saúde Animal), consumer health (Momenta), and a human milk bank (Lactare).

Is eurofarma, sociedad anonima a public or private company?

eurofarma, sociedad anonima is a private company. It is classified as unknown and is currently operating.

When was eurofarma, sociedad anonima founded?

eurofarma, sociedad anonima was founded in 1972. It employs 5,001 to 10,000 people.

Where is eurofarma, sociedad anonima based?

eurofarma, sociedad anonima is headquartered in Itapevi, Brazil, in the Latin America region.

How does eurofarma, sociedad anonima make money?

One revenue line is on record: pharmaceutical Products.

Who are eurofarma, sociedad anonima's main competitors?

Direct peers on record are EMS Pharma, Hypera Pharma, Aché Laboratórios and Biolab Sanus Farmacêutica. Emerging players are Aurobindo Pharma, Aspen Pharmacare and Torrent Pharmaceuticals. Broad incumbents are Eurofarma's Medley/Sanofi (sanofi-aventis Brazil), Bayer Pharmaceuticals and Zoetis.

Does eurofarma, sociedad anonima have an API?

No public API is recorded for eurofarma, sociedad anonima.

What industry is eurofarma, sociedad anonima in?

eurofarma, sociedad anonima's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAJAOAK, Global Supply Chain, Procurement & Market-Shaping Partnerships (Medicines/Diagnostics/Vaccines), with a secondary code of HLAGAHAM, Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC). Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales